Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability as well as the
pharmacodynamic effects of multiple doses of AVX-470 administered orally in patients with
active ulcerative colitis.